Liang W Q, Chen T, Yu J
Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Cancer, Guangzhou 510515, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Aug 25;25(8):741-746. doi: 10.3760/cma.j.cn441530-20220329-00120.
Artificial intelligence (AI) is one of the most rapidly evolving fields in biomedicine during the past decade. Represented by radiomics, machine learning and deep neural network, AI has been increasingly favored by researchers due to its ability to obtain feature information and discover the potential relationship between data and medical outcomes from high-throughput medical data. The incidence and mortality of gastric cancer (GC) has remained high in China. Through combining AI technology with medical examination such as endoscopy, imaging, pathological examination and sequencing, clinical researchers have made great progress in the auxiliary diagnosis, disease staging, prognosis and curative effect prediction of patients with GC. Although the intervention of AI in the medical industry has greatly improved the effective utilization of high-throughput data and accelerated the intelligent process of disease diagnosis and treatment, a number of problems has been raised in medical ethics, patient privacy and the legal status of medical AI at the same time. In the future, rational planning and management of AI technology will provide a strong impetus to promote the development of medicine and reshape the medical industry.
人工智能（AI）是过去十年生物医学领域中发展最为迅速的领域之一。以放射组学、机器学习和深度神经网络为代表，人工智能因其能够从高通量医学数据中获取特征信息并发现数据与医学结果之间的潜在关系，而越来越受到研究人员的青睐。在中国，胃癌（GC）的发病率和死亡率一直居高不下。通过将人工智能技术与内窥镜检查、影像学检查、病理检查和测序等医学检查相结合，临床研究人员在胃癌患者的辅助诊断、疾病分期、预后及疗效预测方面取得了很大进展。尽管人工智能在医疗行业的介入极大地提高了高通量数据的有效利用率，并加速了疾病诊断和治疗的智能化进程，但同时也在医学伦理、患者隐私和医疗人工智能的法律地位等方面引发了一些问题。未来，对人工智能技术进行合理规划和管理将为推动医学发展和重塑医疗行业提供强大动力。
